Xcout Intel
Embolx, Inc.
Embolx, Inc. is a medical equipment manufacturing company located in Sunnyvale, California, recognized as a leader in advanced microcatheter technology for targeted embolization procedures.
Subscribe to see Embolx, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Embolx, Inc. at a glance
Embolx, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $1.6M in October 2022. Xcout tracks 8 named people at Embolx, Inc., including Michael Allen (President & Chief Executive Officer).
Embolx, Inc. leadership
- Michael AllenPresident & Chief Executive Officer
- NORMAN GITISChairman
- Matthew NalipinskiVP of Operations and Engineering
- Robert HornakDirector of Sales
- Haley McGregorGlobal Marketing and Sales Operations
- FRANK GRILLODirector
2 more named people on record for Embolx, Inc., with roles, board committees and tenure — see the full roster →
Embolx, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Embolx, Inc. competitors
A few of Embolx, Inc.'s closest competitors — see the full list of competitors and alternatives →
Integrated Vascular Systems Inc. is headquartered in Sunnyvale, California, and operates within the vascular medical device and systems market.
Cardiva Medical, Inc. is a privately held medical device manufacturer headquartered in Santa Clara, California, specializing in vascular closure and related healthcare products.
Vantis Vascular, Inc. is a pioneering medical technology company headquartered in San Jose, California, founded by physicians to develop advanced vascular intervention solutions such as the CrossFAST performance system.
EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle. This innovative approach aims to address and eliminate the typical difficulties associated with traditional wired leads, such as challenging insertion, unintended nerve activation, device displacement, complex removal procedures, and the need for frequent repositioning. The company was established in 2003 and operates from its headquarters in Sunnyvale, California.
Route 92 Medical is a privately held medical technology company based in San Mateo, California. The company is dedicated to improving patient outcomes through revolutionary procedural changes and advanced neurovascular intervention tools.
Svelte Medical Systems, Inc. is a medical device company headquartered in New Providence, New Jersey, focused on developing advanced cardiovascular technologies and drug-eluting stents.
Get Embolx, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Embolx, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access